White matter hyperintensities and microplastics
Bearer, E. L.; Garcia, M. A.; Adolphi, N. L.; Campen, M. J.
Show abstract
SynopsisWhite matter hyperintensities are abnormalities that appear in MRI scans of living patients but are not apparent in MRI post-mortem. GoalOur goal is to understand the cellular/biological basis of white matter hyperintensities (WMH). ApproachWe aligned post-mortem MR scans with those collected ante-mortem and performed histopathology and pyrGC/MS for plastics on regions with WMH. ResultPyrGC/MS detected large amounts of plastics and we determined their cellular locations with a novel optical imaging approach in regions with small vessel disease and Abeta plaques. ImpactMicroplastics in the brains of people with cognitive impairment may be due to pre-existing vascular injury or contribute to it. Many questions remain: Where do they come from, do they impair function? Can they be diagnosed by MRI ante-mortem?
Matching journals
The top 8 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Apolipoprotein E abundance is elevated in the brains of individuals with Down syndrome-Alzheimer's disease 94%
- Isomerized Aβ in the brain can distinguish the status of amyloidosis in the Alzheimer's Disease spectrum 94%
- Brain Vasculature Accumulates Tau and Is Spatially Related to Tau Tangle Pathology in Alzheimer's Disease 93%
Similar papers in this journal
- Retinal tau phosphorylation in Alzheimer's disease: a mass spectrometry study 94%
- Non-linear microglial, inflammatory and oligodendrocyte dynamics across stages of Alzheimer's disease 94%
- An interim exploratory biomarker analysis of a Phase 2 clinical trial to assess the impact of CT1812 in Alzheimers disease 93%
Similar papers in this journal
- Comparative profiling of the synaptic proteome from Alzheimer’s disease patients with focus on the APOE genotype 93%
- Emergence of distinct and heterogeneous strains of amyloid beta as Alzheimer s disease progresses in Down syndrome 93%
- Iron-loading is a prominent feature of activated microglia in Alzheimer's disease patients 92%